A North Amercian Setback
WHY ITALIANS DO IT BETTER
Italy bans all Genetically Modified Foods (“GMO”), as well as Glyphosate otherwise known as Round-Up (“Round-Up”). SEEDS IN ITALY CAN NOT BE TREATED WITH A ROUND-UP. Italians do not even expose their livestock to GMO or Round-Up. Italy's agriculture sector continues to lead the European Union on the No GMO stance.
Age-standardized cancer and alzheimer rates in Italy have gone down over the last few decades, however, the absolute number of cancer and alzheimer cases and deaths have increased, due to the progressive ageing of the population. The italian population is rapidly decreasing and its government is doing everything it can to preserve life and future generations.
How Round-Up & GMO Hurt
Round-Up has been shown to disrupt gut bacteria in animals, killing beneficial forms of bacteria and causing an overgrowth of pathogens. Studies have shown that low dose of Round-Up can cause intestinal damage, and lead to changes in the gut microbiome composition in mice, leading to behavioural changes similar to neurodevelopmental disorders.
Bacterial imbalance of our good and bad bugs, is a leading cause of the leaky gut syndrome destroying our mitochondria and gut health. Recently, there has been research on unhealthy gut and impaired glucose tolerance which increases the risk for insulin resistance.
Studies show that insulin resistance was associated with gut permeability without a direct influence of obesity in young adults. Canadians with a healthy BMI are now also insulin resistant. Round-Up is used excessively in Canada. Grass seeds, fruit and vegetable seeds are all treated with Round-Up.
More than a Gut Feeling
Imbalances in the gut can trigger the body’s immune response. Environmental factors that we cannot control are affecting the gut bacteria of all Canadians. Insulin resistance is on the rise, type 3 diabetes is on the rise. North Americans cannot control their exposure to Round-Up unless we all move to Italy. Healing our guts through disease preventative foods is not only an option but the quality of our geriatric lives literally depend on it.
Several epidemiological studies suggest reduction of cognitive diseases and cancer in the Italian/Mediterranean population, whencompared to other European and American counterparts, mainly due to the consumption of EVOO as a key dietary component. This study came to the conclusion, the earlier the EVOO was taken the more effective it was at preventing cancer and Alzheimer’s disease. Additionally, the animal trials demonstrated that the preventive mode was much more effective than the treatment mode of using EVOO for its polyphenol benefits.
Our Second Brain
Emerging evidence is showing that the gut–brain axis is one of the most powerful relationships in our body. Dysregulation of the gut flora has been correlated with a host of inflammatory and autoimmune conditions.
The gut microbiome is a group of microorganisms of bacteria, archaea, fungi, and viruses take possession of the gastrointestinal tract. The gut microbiome regulates various metabolic pathways, including those involved in energy balance linked to the hypothalamus in the brain, glucose and lipid metabolism, and bile acid metabolism. The relationship between changes in intestinal microbiota otherwise known as imbalances in the gut microbiome leads to dysbiosis (cell death) which leads to diverse diseases, such as metabolic syndrome, cardiovascular diseases, celiac disease, inflammatory bowel disease, and neurological disorders. Multiple factors affect the microbiota and how it physically functions, but one of the major factors triggering gut microbiome establishment is DIET.
The typical North American diet leads to the typical and predictable North American diseases. The good news is that if diet can harm your gut microbiome, a change in diet can heal your gut microbiome!!
Harvard has been studying this for decades!
“Excellence is never an accident.
It is always the result of
high intention, sincere effort and intelligent execution;
the wise choice
of many alternatives choice,
determines your destiny.”
The Harvard Studies 1976 - Present
Harvard, MIT, UC Berkeley, and Yale have all joined forces with the University of Athens. Why do these ivy leagues Universities want to join forces with the University of Athens? The University of Athens has 18 Centers of Expertise, in Rare Diseases of the School of Medicine, and specialize in the rare patient.
Dr. Stefanos Kales, Professor of Medicine at Harvard Medical School, Prokopios Magiatis Professor of School of Pharmacy of University of Athens, Dr. Eleni Melliou, Diomedes Lopothetis, Baltopoulos George, and Dan Flynn are making history in a new era of medicinal extra virgin olive oil to better humanity by disease prevention.
Harvard has a long history studying EVOO and its affect to the body. Harvard ran two studies simultaneously, one began in 1976 and the other in 1986 and collectively involved about 200,000 people. Harvard study published in the Journal of the American College of Cardiology concluded that greater consumption of olive oil was associated with lower risk of total and cause-specific mortality — especially when olive oil replaces butter, margarine, or mayonnaise. The scientists found that participants reporting Southern European and/or Mediterranean ancestry had higher consumption of olive oil; they had a 6% lower risk of total mortality, slightly more pronounced than the 4% risk reduction in the non-Mediterranean ancestry subgroups. Harvard’s results support current dietary recommendations to increase the intake of olive oil in place of other fats to improve overall health and longevity.
Dr. Kales and the US Department of Homeland Security, have recently conducted a trial involving 350 firefighters and 44 fire stations. In America, it has been found that cardiovascular disease is the leading cause of on-duty deaths of firefighters. The ultimate purpose of the study is to lower firefighters' risks for Cardiovascular Diseases and Cancer through a prevention model by successfully getting more firefighters and their families to adopt and incorporate the healthy eating principles behind the Mediterranean diet with the primary source of fat being EVOO.
This recent preventative nutritional intervention trial among US career firefighters showed improved adherence among the MDNI group compared to the control group. These findings suggest the Mediterranean diet is a valid dietary pattern recommendation for this non-Mediterranean working population.
The Harvard study seems to reconfirm the findings of Ancel Keys and the Mediterranean Diet. UNESCO declared the Mediterranean diet as an intangible cultural heritage in 2010 and Italy was one of the first Mediterranean countries mentioned. In this 2010 UNESCO description transmitting knowledge of the Mediterranean diet and safeguard its techniques, respect seasonal.
people who lunch
Professor Stefanos Kales
Professor Harvard Medical School
Professor & Director Occupational Medicine TH Chan School of Public Health
Medical Director for Employee Health at Cambridge Health Alliance
Professor Irene Lidoriki
Harvard Medical School
Occupational Medicine TH Chan School of Public Health Medical Cambridge Health Alliance
SCIENTIFIC EVALUATION REPORT
We are humbled and grateful to have qualified for a Scientific Evaluation Report from the Department of Pharmacy of the University of Athens stating that EVOO Previ stands out for its enhanced properties for health protection by one of the most respected medical scientist in the entire European Union, Prokopios Magiatis.
Who is Prokopios Magiatis and why should I trust his report?
Prokopios Magiatis, Ph.D., M.Sc., is associate Professor at the Faculty of Pharmacy of the University of Athens Laboratory of Pharmacognosy and Chemistry of Natural Products. He graduated from the same Faculty in 1994 and defended his Ph.D. in 2000. In 2001, he did his postdoctoral research at the Curie Institute in Paris, France. He has worked as a visiting professor at the University of California, Davis.
Since 2002 he has been working on olive products and especially on olive oil. He has invented five indirubin derivativescommercially available as pharmacological tools and he is an author of 140 publications and 14 patents.
He was awarded the 2009 Egon-Stahl silver medal as the top scientist under 40 years old in the field of natural-products chemistry and pharmacology. His research is focused on the isolation, chemical synthesis, and bioactivity of natural products, especially those reported in ancient medical texts. He has been awarded as the Inventor of the Year 2016.
If that isn't enough how about the top medical scientists in North America seem to be interested in working along side him.